Red Door Wealth Management LLC Purchases 52,851 Shares of Core Scientific, Inc. (NASDAQ:CORZ)

Red Door Wealth Management LLC grew its position in Core Scientific, Inc. (NASDAQ:CORZFree Report) by 124.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 95,378 shares of the company’s stock after acquiring an additional 52,851 shares during the period. Red Door Wealth Management LLC’s holdings in Core Scientific were worth $1,340,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of CORZ. Shikiar Asset Management Inc. boosted its stake in Core Scientific by 27.0% in the fourth quarter. Shikiar Asset Management Inc. now owns 95,250 shares of the company’s stock worth $1,338,000 after purchasing an additional 20,250 shares in the last quarter. FNY Investment Advisers LLC grew its holdings in Core Scientific by 35.8% during the 4th quarter. FNY Investment Advisers LLC now owns 190,747 shares of the company’s stock worth $2,679,000 after acquiring an additional 50,275 shares during the last quarter. ORG Wealth Partners LLC increased its position in Core Scientific by 0.3% in the 4th quarter. ORG Wealth Partners LLC now owns 8,986,651 shares of the company’s stock valued at $126,262,000 after acquiring an additional 26,649 shares in the last quarter. Wealth Enhancement Advisory Services LLC raised its stake in shares of Core Scientific by 25.6% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 98,077 shares of the company’s stock worth $1,378,000 after acquiring an additional 20,000 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its position in shares of Core Scientific by 48.0% during the third quarter. JPMorgan Chase & Co. now owns 437,812 shares of the company’s stock worth $5,192,000 after purchasing an additional 142,068 shares in the last quarter.

Analyst Ratings Changes

CORZ has been the topic of several research reports. Craig Hallum began coverage on Core Scientific in a report on Tuesday. They set a “buy” rating and a $24.00 price objective on the stock. HC Wainwright boosted their price objective on Core Scientific from $15.00 to $17.00 and gave the stock a “buy” rating in a report on Thursday, November 7th. Roth Mkm assumed coverage on shares of Core Scientific in a research note on Friday, November 15th. They issued a “buy” rating and a $25.50 target price on the stock. Cantor Fitzgerald reissued an “overweight” rating and set a $20.00 price target on shares of Core Scientific in a research note on Thursday, October 3rd. Finally, Jefferies Financial Group assumed coverage on shares of Core Scientific in a report on Monday, October 28th. They set a “buy” rating and a $19.00 target price for the company. Fourteen equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Core Scientific presently has a consensus rating of “Buy” and an average price target of $18.86.

View Our Latest Stock Report on Core Scientific

Core Scientific Trading Up 2.3 %

CORZ opened at $16.34 on Friday. The stock has a market capitalization of $4.56 billion and a P/E ratio of -3.02. Core Scientific, Inc. has a 12 month low of $2.61 and a 12 month high of $18.63. The firm’s fifty day simple moving average is $15.54 and its 200 day simple moving average is $12.90.

Core Scientific (NASDAQ:CORZGet Free Report) last posted its quarterly earnings data on Wednesday, November 6th. The company reported ($0.13) earnings per share for the quarter, missing the consensus estimate of ($0.11) by ($0.02). The firm had revenue of $95.35 million during the quarter, compared to the consensus estimate of $94.80 million. On average, equities research analysts predict that Core Scientific, Inc. will post 0.5 EPS for the current fiscal year.

Insider Activity

In related news, Director Yadin Rozov sold 105,000 shares of Core Scientific stock in a transaction dated Friday, November 22nd. The stock was sold at an average price of $18.11, for a total value of $1,901,550.00. Following the sale, the director now owns 345,239 shares of the company’s stock, valued at approximately $6,252,278.29. The trade was a 23.32 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Todd M. Duchene sold 129,861 shares of the stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $14.24, for a total value of $1,849,220.64. Following the transaction, the insider now directly owns 2,051,649 shares of the company’s stock, valued at $29,215,481.76. This trade represents a 5.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 348,241 shares of company stock worth $5,436,802 over the last ninety days. Insiders own 32.00% of the company’s stock.

Core Scientific Company Profile

(Free Report)

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.

Featured Articles

Institutional Ownership by Quarter for Core Scientific (NASDAQ:CORZ)

Receive News & Ratings for Core Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Scientific and related companies with MarketBeat.com's FREE daily email newsletter.